Profitability improved faster than revenue. Non-GAAP operating income rose 40% to $2.1 billion, or 3.7% of gross bookings, up ...
Q3: Why is ONDS stock down in 2026? A3: ONDS is down about 35% in 2026 as investors weigh share dilution from equity raises, ...
Iovance Biotherapeutics (NASDAQ: IOVA) rose about 12% after hours on October 28 after announcing positive results from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results